Memantine (Namenda) just got approved for Alzheimer's

November 2003

Memantine (Namenda) just got approved for Alzheimer's.

It's been used for years in Europe as brand-name Ebixa. It'll hit U.S. pharmacies Jan '04. There will be a HUGE demand.

Memantine is approved for moderate to SEVERE Alzheimer's.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

who should take a daily aspirin...and how much they should take
Alzheimer Disease Memantine (Namenda) just got approved for Alzheimer's
Cardiology new warnings about a potential interaction between cranberry juice and warfarin
Cardiology More heart failure patients will be taking an aldosterone antagonist
Osteoporosis thiazide diuretics reduce the risk of fractures from osteoporosis
Osteoporosis combo treatment for osteoporosis in postmenopausal women
Shingles Does the chickenpox vaccine (Varivax) prevent shingles?
new protease inhibitor called Lexiva
Infectious Diseases antibiotic suspensions that DON'T need refrigeration...DisperMox and Panixine Disperdose
Infectious Diseases new injectable antibiotic called Cubicin
Hematology & Oncology Femara (letrozole) to prevent recurrent breast cancer
Men's Health Levitra will work in some men who don't respond to Viagra
possible link between atypical antipsychotics and diabetes
Zomig NASAL SPRAY
confusion between the new Darvocet A500 and Darvocet-N 100
Medication Errors Look- and sound-alike drug names are creating mistakes